Skip to main content
. Author manuscript; available in PMC: 2021 Sep 21.
Published in final edited form as: J Peripher Nerv Syst. 2021 Jan 23;26(1):4–16. doi: 10.1111/jns.12431

FIGURE 3.

FIGURE 3

Schematic representing the different approaches to pharmacologically target the Hippo pathway. Group I drugs enhance phosphorylation of YAP/TAZ. Group II drugs directly modify the YAP/TAZ-TEAD interaction. Group III drugs target the genes regulated by YAP/TAZ-TEAD